Complimentary Dinner Symposium

Overview:

Lipoprotein(a) (Lp[a]) has been proven to be a potent, common, independent risk for atherosclerotic cardiovascular disease  (ACHD)and calcific aortic stenosis.  Elevated Lp(a) is a genetic issue affecting 1 in 5 people and contributes significantly to ACHD. This program will clarify the role of Lp(a) as a genetically driven cause of ASCVD and its significant implications for revising the calculation of individuals’ cardiovascular  risk, the appropriate management of coexisting risk factors, and  identify  targets for potential gene-altering, preventative interventions. 

Learning Objectives:

• Describe the structure and normal metabolism of Lp(a).
• Recognize the associative risk of cardiovascular disease, including aortic stenosis with elevated LP(a).
• Explain the prevalence and mechanism of action of elevated Lp(a) levels.
• Appraise present and potential future therapeutic options for elevated Lp(a).